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CCF advocates to ensure improved services and facilities. We represented the childhood cancer
patient cohort at the New National Cancer Strategy 2016-2025 working group and during the
New National Children’s Hospital planning stages.
Results: CCF supports all children aﬀected by cancer by working with Ireland’s National Pae-
diatric Oncology Centre to introduce and fund psycho-social support programmes including
play services, Beads of CourageTM and a complementary therapy services research project. We
collaborate with the Irish Cancer Society on provision of information and developing a Parent
Peer To Peer Support Programme.
Conclusion: By telling our story, this presentation shows how a dedicated parent group has
collaborated with medical professionals, policy makers, national and international stakeholders
to establish a national paediatric oncology organisation to help ease the trauma and isolation
of a childhood cancer diagnosis on children, their families and the wider community.
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Background/Objectives: Treatment of cancer in refugees is of increasing importance, it
causes a substantial burden on the health systems of the host countries. We aimed to eval-
uate the demographic features and outcome of refugee children with cancer, mostly Syrian,
treated in Turkey and to evaluate the problems encountered.
Design/Methods: A survey on the demographic data, treatment and outcome of cancer in
refugee children in Turkey was conducted. The records of refugee children with cancer treated
in various regions in Turkey between June 2011 and October 2015 were evaluated retrospec-
tively.
Results: Twohundredandtwelve (212) children with cancer treated in 17 centers in 10 cities
were evaluated retrospectively, 197 patients were from Syria. Male: female ratio was 1.5.
Median age was 5 years (1-17 years). The diagnosis were acute leukaemia in 52 (24,5%),
lymphomas in 35 (16,5%), brain tumors in 31 (14,6%), neuroblastoma in 29 (13,6%), bone
and soft tissue sarcomas in 34 (16%), Wilms tumour in 13 (6,1%) and other. The frequency
of neuroblastomas (p<0.0005) and bone tumors (p=0.0058) in refugee children were higher
than in Turkish children. Fifteen patients underwent hematopoietic stem cell transplantation.
Most patients (67,6%) were treated in the south and southeast of Turkey close to the border. All
treatment for registered refugees has been provided free of charge. 159 (75%) patients are alive,
31 (14,6%) have died, 22 (10,3%) were lost to follow up. The most frequent problems encoun-
tered were accomodation, social and psychological problems, language barriers, compliance
with therapy and financial problems.
Conclusion: The distribution of most types of cancer and preliminary outcome in refugees
was similar to children in Turkey. Shelter, hygiene, language barriers, compliance were major
problems. Preliminary results of this survey may help to inform future responses in children
with cancer who are forced to migration.
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Background/Objectives: Lund Vietnam Childhood Cancer Program has been active in Viet-
nam since 2008. We have identified 9 hospitals in 4 cities treating children with malignant
diseases. The epidemiology of paediatric malignancies, follow up, and survival data are frag-
mented. Bringing together institutions and staﬀ dealing with paediatric cancer in one network
creates conditions for further development of paediatric oncology in Vietnam.
Design/Methods: A web based online registration program was designed. The patients’
records contain demographic data and medical information (diagnosis according to ICCC, type
and start of treatment). The program permits registration of follow up visits with specification
of contact reason and certain events: relapse, abandonment, lost-to-follow-up or death. Elec-
tronic transfer of patients between hospitals is possible. Visualization with figures showing
real-time registration status and disease distribution, both at the national and local, level is
available. Kaplan-Meier survival curves for diagnoses or groups of patient are drawn automat-
ically. A flexible filter and export function is featured. Notifications are generated if the records
are not updated for a certain time period.
The database was created to register malignant diseases and was subsequently extended to
register children with non-malignant hematological diseases.
The next step is to initiate an inbuilt calendar function that will allow for scheduling of coming
visits.
Results: The registration was launched on the 1st of August 2015 in 9 hospitals. 2,250 children
have been registered until March 2016 (66% malignancies, 34% non-malignant hematological
diseases, monthly registration ranges from 167 to 482 patients).
Conclusion: This is the first nation-wide registry for paediatric haematology and oncology in
Vietnam. It can be used by health care providers and policy makers for more eﬃcient allocation
of resources.
This registry allows for better control of follow up and may identify main problems influencing
the outcome. It is also a ready-to-use platform for future clinical and epidemiological trials.
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Background/Objectives: Among disease- or treatment-related long-term eﬀects of childhood
cancer, peripheral neuropathies, deficits in global coordination, balance, attention capacity and
quality of life have been demonstrated. Several publicationsmention a potential benefit of phys-
ical activity in improving long term outcome of such complications. Our study aimed primar-
ily at evaluating the feasibility of a weekly physical activity program for children with cancer
and secondly at assessing if the type of physical activity proposed could impact the pattern of
improvement.
Design/Methods: We set up a weekly, 1-hour program of physical activity during the school
year from august 2015 to June 2016. 24 patients aged 6 to 18 years with various types of tumors
were approached and asked to participate. Included patients were separated in two age-groups
(6-11 and 12-18 years) and randomized to have either pure physical or physical/attentional
activities. After 5 months, patients were crossed-over in the other group. Neurological, coor-
dination, neuropsychological and fitness testing were administered at 4 time-points during the
study. Individual distance and speed was recorded at each session by a dedicated camera.
Results: As the study is ongoing, most of the evaluation results will only be available after
the planned termination in June 2016 and will be analyzed and reported on the final poster.
Twenty-three patient on the 24 approached accepted to participate, one dropped oﬀ after after
2 months. Attendance after 8 months is 81% (SD 15%), which is slightly above the 80% limit
that we had set to consider a weekly schedule as feasible.
Conclusion: Final results are not yet available as the study termination is planned for June
2016. Attendance after the first part is good at 81% of the sessions. Oﬀering such a program
once every two weeks could potentially decrease the burden put on families of a weekly sched-
ule and improve attendance.
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Background/Objectives:The tone and quality of the parental relationship has profound eﬀects
on the physical, emotional, mental, and spiritual health of the child. A child’s relationship with
parents is often the most significant relationship influencing the child’s well being; in fact, this
relationship has formative and lasting imprints on a child. The state of the marital relationship
itself has impact on the child so attending to the parents’ relationship is primary prevention in
caring for the child. This study oﬀers a deep understanding of the eﬀects of childhood cancer
on the parental relationship.
Design/Methods: Data consisted of the content of 24 interviews with a total of 30 partici-
pants. Data analysis of the transcribed interviews was conducted using the research method of
hermeneutics. Of the interviews, 10 were individuals/couples whose child had died; 7 where
the child had lived but was experiencing long term side eﬀects; 7 had a child treated, cured,
and living with little to no side eﬀects.
